"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revasc… (NCT07273513) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients
951 participantsStarted 2026-01-15
Plain-language summary
This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18-80 years.
* Underwent CABG or PCI more than 3 months prior and have concurrent hypertension, diabetes, and dyslipidemia.
* At least one of the following criteria is meet:
* Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg
* HbA1c no less than 7%
* LDL-C no less than 1.4 mmol/L
* Signed informed consent.
Exclusion Criteria:
* History of heart failure or severe arrhythmias.
* Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.
* Pregnancy, lactation, or plans for pregnancy within the next year.
* Cognitive, communication impairments, or limitations in daily activities.
* Unable to use smartphone.
What they're measuring
1
The control rates of hypertension, diabetes and hyperlipidemia
Timeframe: 6-month
Trial details
NCT IDNCT07273513
SponsorChina National Center for Cardiovascular Diseases